The potential of Oxitec’s GM Mosquitoes

Mosquito-borne diseases, such as dengue fever, Zika, chikungunya and malaria, are major and increasing international public health concerns. The two main vectors of dengue are Aedes aegypti and Aedes albopictus and current control measures are proving difficult against both these mosquitoes. In an Oxitec control programme transgenic male mosquitoes (male mosquitoes do not bite or transmit disease) are released continually over a wide area to mate with the target pest population; progeny from these matings die and the target population declines. Over 150 million genetically engineered Oxitec male mosquitoes have been released over the past 6 years in trials around the world. I will present about what this has achieved and future prospects around the world.

AMCA Members - This archived webinar along with all AMCA webinars is available free to our active members. We are currently syncing this new system with our database to have seamless identification of our members, but until that is finalized you can access all webinars (live and archived) for free using our membership code which can be found in our member portal here.